From regulatory strategy to quality systems and product commercialization, our experts share practical guidance to help medical device, pharmaceutical, and biotech companies accelerate compliance and reduce risk.
Robotic surgery continues to advance, bringing together sophisticated hardware, software, user interfaces, surgical instruments, and increasingly complex clinical applications.
For medical device developers, this complexity creates an equally important regulatory challenge: building an evidence strategy that evolves alongside the technology.
The Next Decade of Medical Device Innovation: Why Regulatory Science Must Evolve With Technology. On September 25, 2026, the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) and the Medical Device Innovation Consortium (MDIC) convened a public meeting titled “Regulatory Science Innovations Catalyzing Medical Device Development.”
